瘫痪康复汤对气虚血瘀缺血性中风恢复期的疗效分析

Objective To evaluate the clinical efficacy of the Paralysis Rehabilitation Decoction in treating patients with ischemic stroke in the recovery period who have the main syndrome of qi deficiency and blood stasis. Methods From September 2021 to September 2025, 138 patients with ischemic stroke in the recovery period who met the syndrome of qi deficiency and blood stasis were selected and randomly divided into two groups, with 69 cases in each group. The control group received conventional western medical treatment, while the observation group received the Paralysis Rehabilitation Decoction orally in addition to the treatment of the control group. During the treatment period, the neurological function, quality of life, limb movement function, and TCM syndrome scores as well as the living ability of the two groups of patients were compared, and the occurrence of adverse reactions was recorded. Results After treatment, the National Institutes of Health Stroke Scale(NIHSS) score of the observation group was lower than that of the control group, and the Stroke-Specific Quality of Life Scale(SS-QOL) score was significantly higher, and the differences were statistically significant(P<0.05). In terms of TCM syndrome and limb movement function improvement, the scores of the observation group were lower than those of the control group, and the limb function scores were higher than those of the control group(P<0.05). The Activities of Daily Living(ADL) score of the observation group was higher than that of the control group(P<0.05). The total incidence of adverse reactions during the treatment process of the two groups was similar, and the difference was not statistically significant(P>0.05). Conclusion The Paralysis Rehabilitation Decoction is helpful in improving the neurological function, limb movement function and quality of life of patients with ischemic stroke in the recovery period with qi deficiency and blood stasis syndrome. It can effectively alleviate neurological deficit symptoms and related clinical manifestations. The treatment process is safe and has good clinical applicability.